Five new stationary phases for BlueOrchid UHPLC columns
Knauer Product Profile
KNAUER introduced five new stationary phases for its BlueOrchid 1.8 µm columns, extending the range of available selectivities to a total of twelve.
The new BlueOrchid UHPLC columns include C4, SAX, HILIC, PAL-HILIC phases and an amino phase.
BlueOrchid columns are designed to provide high efficiency and stability, making them the ideal choice for demanding applications. All BlueOrchid columns are packed with 1.8 μm particles and feature a very narrow particle size distribution resulting in one of the lowest column back pressures in its class. BlueOrchid columns also offer outstanding peak symmetry, even for basic compounds.
These new BlueOrchid columns now make it possible to use UHPLC for fast separation of proteins and peptides, small organic molecules such as nucleotides and organic acids, highly hydrophilic compounds, anionic species and other polar compounds, as well as sugars and carbohydrates.
KNAUER, Berlin, Germany, www.knauer.net
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
